TRP channels: emerging targets for respiratory disease

Area of Science:

• Physiology
• Pharmacology
• Respiratory Medicine

Background:

• Mammalian transient receptor potential (TRP) superfamily comprises six subfamilies (TRPC, TRPV, TRPM, TRPA, TRPP, TRPML).
• TRP channels are expressed in sensory nerves and various cell types, implicated in respiratory diseases like asthma and COPD.
• These channels respond to diverse physical and chemical stimuli, including temperature, osmotic stress, capsaicin, menthol, and acrolein.

Purpose of the Study:

• To review the evidence for TRP channel modulation in treating key features of respiratory diseases.
• To explore novel therapeutic strategies targeting TRP channels for asthma and COPD.

Main Methods:

• Literature review of studies investigating TRP channel function and modulation in respiratory contexts.
• Analysis of evidence linking TRP channel activity to asthma and COPD pathophysiology.
• Focus on selective TRP channel blockers as potential therapeutic agents.

Main Results:

• TRP channels play a significant role in airway inflammation, hyper-reactivity, mucus secretion, and cough.
• Evidence suggests that selective modulation of TRP channels can ameliorate these disease features.
• TRP channel blockers represent promising therapeutic candidates for respiratory conditions.

Conclusions:

• Targeting specific TRP channels offers a novel therapeutic avenue for managing asthma and COPD.
• Further research into TRP channel modulators could lead to effective treatments for respiratory diseases.
• Modulation of TRP channels holds potential for alleviating symptoms such as inflammation, hyper-reactivity, and cough.